Private Equity Firm

Everstone buys majority stake in Indian drug delivery firm Rubicon

Everstone, a private equity firm specializing in India and Southeast Asia, has finally decided to shell out Rs 220 crore ($33 million) to obtain a 70% stake--a much larger piece of the pie than suggested by previous speculations--in Rubicon Research, an Indian drug delivery company.